CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

re: Ann: Omacetaxine European rights licensed... $18m up front,...

  1. 1,539 Posts.
    lightbulb Created with Sketch. 5
    re: Ann: Omacetaxine European rights licensed... $18m up front, with another $120m in milestone payments.

    Should be enough to support Chemgenex's direct marketing and sales in the US market.

    Together with the evidence for the extra indication (TKI failures without T315I mutation), this is looking pretty good!
 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.